Acute Leukemia and Myeloid Malignancies Rounds Philadelphia
May 2, 2024
Format
New Live, In-Person Event
*Pre-registration required
Live interactive continuing medical education activity for healthcare professionals in Philadelphia and the surrounding areas to discuss acute leukemia and myeloid malignancies updates and challenges in treatment.
Target Audience
This activity is intended for hematologists-oncologists, medical oncologists, physician associates, advanced practice providers, nurses, and pharmacists involved in the care of patients with leukemia and myeloid malignancies.
Agenda
5:45 PM – Dinner and Networking
6:30 PM – Welcome, Overview of Program and Overview of Updates in Treatment
Catherine Lai, MD, MPH
6:40 PM – Overview of LLS Resources
Amanda O'Neill, LMSW and Ruby Nava-Ramos, MPH
6:50 PM – Case Presentation and Discussion on Ph-positive Acute Lymphoblastic Leukemia (ALL)
Rashmi Khanal, MD and Anthony Stack, DO
7:20 PM – Case Presentation and Discussion on Myelofibrosis
Lindsay Wilde, MD and Quinto Gesiotto, MD, MS
7:50 PM – Case Presentation and Discussion on FLT3-positive Acute Myeloid Leukemia (AML)
Alexander Perl, MD, MS and Xin Wang, MD, PhD
8:20 PM – Panel discussion and wrap up
All Faculty
8:30 PM – Conclusion
Catherine Lai, MD, MPH
Educational Objectives
At the conclusion of this activity, participants will be better able to:
- Explain the most recent data on novel treatment options in acute leukemias and myeloid malignancies
- Discuss drug interactions with novel therapies and how to manage
- Explain diagnostic and prognostic testing and challenges, relapse prevention and detection of measurable residual disease
- Access resources for patient education and support
Advisory Group
Catherine Lai, MD, MPH (Chair)
Hospital of the University of Pennsylvania
Philadelphia, PA
Katie Allen, CRNP
Hospital of the University of Pennsylvania
Philadelphia, PA
Alison Carulli, PharmD, BCOP
Hospital of the University of Pennsylvania
Philadelphia, PA
Margaret Kasner, MD, MSCE
Jefferson Health
Philadelphia, PA
Grace Shyu, PA-C
Hospital of the University of Pennsylvania
Philadelphia, PA
Michael Styler, MD
Fox Chase Cancer Center
Philadelphia, PA
Faculty
Catherine Lai, MD, MPH (Chair)
University of Pennsylvania
Philadelphia, PA
Quinto Gesiotto, MD, MS
Jefferson Health
Philadelphia, PA
Rashmi Khanal, MD
Fox Chase Cancer Center
Philadelphia, PA
Ruby Nava-Ramos, MPH
The Leukemia & Lymphoma Society
Rye Brook, NY
Amanda O'Neill, LMSW
The Leukemia & Lymphoma Society
Rye Brook, NY
Alexander Perl, MD, MS
University of Pennsylvania
Philadelphia, PA
Anthony Stack, DO
Fox Chase Cancer Center
Philadelphia, PA
Xin Wang, MD
University of Pennsylvania
Philadelphia, PA
Lindsay R. Wilde, MD
Jefferson Health
Philadelphia, PA
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate
Medical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 2.0 continuing education contact hour through the California Board of Registered Nursing.
Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-24-027-L01-P
Type of Activity: Application
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Learners must participate in the entire CE activity, complete, and submit the evaluation form to earn credit. Once submitted, the certificate will be generated. If you have questions regarding the receipt of your certificate, please contact via email at ndane@mlieducation.org.
For Pharmacists, Medical Learning Institute will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/
Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc.
Supporters
This activity is supported by an educational grant from Rigel Pharmaceuticals, Inc.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.